Matches in SemOpenAlex for { <https://semopenalex.org/work/W2044332216> ?p ?o ?g. }
- W2044332216 endingPage "5650" @default.
- W2044332216 startingPage "5640" @default.
- W2044332216 abstract "By taking advantage of the excessively upregulated expression of neuropilin (NRP) on the surface of both glioma cells and endothelial cells of angiogenic blood vessels, the ligand of NRP with high affinity - tLyp-1 peptide, which also contains a CendR motif ((R/K)XX(R/K)), was functionalized to the surface of PEG-PLA nanoparticles (tLyp-1-NP) to mediate its tumor homing, vascular extravasation and deep penetration into the glioma parenchyma. The tLyp-1-NP was prepared via a maleimide-thiol coupling reaction with uniformly spherical shape under TEM and particle size of 111.30 ± 15.64 nm. tLyp-1-NP exhibited enhanced cellular uptake in both human umbilical vein endothelial cells and Rat C6 glioma cells, increased cytotoxicity of the loaded PTX, and improved penetration and growth inhibition in avascular C6 glioma spheroids. Selective accumulation and deep penetration of tLyp-1-NP at the glioma site was confirmed by in vivo imaging and glioma distribution analysis. The longest survival was achieved by those mice bearing intracranial C6 glioma treated with PTX-loaded tLyp-1-NP. The findings here strongly indicate that tLyp-1 peptide-functionalized nanoparticulate DDS could significantly improve the efficacy of paclitaxel glioma therapy." @default.
- W2044332216 created "2016-06-24" @default.
- W2044332216 creator A5000245553 @default.
- W2044332216 creator A5000363531 @default.
- W2044332216 creator A5002855077 @default.
- W2044332216 creator A5012763993 @default.
- W2044332216 creator A5025104162 @default.
- W2044332216 creator A5028620086 @default.
- W2044332216 creator A5048762031 @default.
- W2044332216 creator A5053670205 @default.
- W2044332216 creator A5066792775 @default.
- W2044332216 creator A5072475973 @default.
- W2044332216 creator A5082857859 @default.
- W2044332216 creator A5088958812 @default.
- W2044332216 date "2013-07-01" @default.
- W2044332216 modified "2023-10-15" @default.
- W2044332216 title "Glioma therapy using tumor homing and penetrating peptide-functionalized PEG–PLA nanoparticles loaded with paclitaxel" @default.
- W2044332216 cites W1966469065 @default.
- W2044332216 cites W1968754817 @default.
- W2044332216 cites W1975992482 @default.
- W2044332216 cites W1976041621 @default.
- W2044332216 cites W1976820765 @default.
- W2044332216 cites W1980539005 @default.
- W2044332216 cites W1981177136 @default.
- W2044332216 cites W1986666514 @default.
- W2044332216 cites W2002516695 @default.
- W2044332216 cites W2003933044 @default.
- W2044332216 cites W2004693405 @default.
- W2044332216 cites W2005451446 @default.
- W2044332216 cites W2011350835 @default.
- W2044332216 cites W2013184812 @default.
- W2044332216 cites W2014537537 @default.
- W2044332216 cites W2024059336 @default.
- W2044332216 cites W2026250154 @default.
- W2044332216 cites W2027432937 @default.
- W2044332216 cites W2035304807 @default.
- W2044332216 cites W2036044314 @default.
- W2044332216 cites W2037646770 @default.
- W2044332216 cites W2044350044 @default.
- W2044332216 cites W2052606768 @default.
- W2044332216 cites W2061593819 @default.
- W2044332216 cites W2066336297 @default.
- W2044332216 cites W2069661123 @default.
- W2044332216 cites W2072388319 @default.
- W2044332216 cites W2079142824 @default.
- W2044332216 cites W2082575848 @default.
- W2044332216 cites W2111139469 @default.
- W2044332216 cites W2117553516 @default.
- W2044332216 cites W2123647020 @default.
- W2044332216 cites W2127167775 @default.
- W2044332216 cites W2133256311 @default.
- W2044332216 cites W2136445803 @default.
- W2044332216 cites W2139008103 @default.
- W2044332216 cites W2140088548 @default.
- W2044332216 cites W2140933650 @default.
- W2044332216 cites W2145502867 @default.
- W2044332216 cites W2146404579 @default.
- W2044332216 cites W2153200726 @default.
- W2044332216 cites W2163326536 @default.
- W2044332216 cites W2167798860 @default.
- W2044332216 cites W2168055604 @default.
- W2044332216 cites W2168587151 @default.
- W2044332216 cites W2312553706 @default.
- W2044332216 cites W4244344354 @default.
- W2044332216 doi "https://doi.org/10.1016/j.biomaterials.2013.04.025" @default.
- W2044332216 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23639530" @default.
- W2044332216 hasPublicationYear "2013" @default.
- W2044332216 type Work @default.
- W2044332216 sameAs 2044332216 @default.
- W2044332216 citedByCount "149" @default.
- W2044332216 countsByYear W20443322162013 @default.
- W2044332216 countsByYear W20443322162014 @default.
- W2044332216 countsByYear W20443322162015 @default.
- W2044332216 countsByYear W20443322162016 @default.
- W2044332216 countsByYear W20443322162017 @default.
- W2044332216 countsByYear W20443322162018 @default.
- W2044332216 countsByYear W20443322162019 @default.
- W2044332216 countsByYear W20443322162020 @default.
- W2044332216 countsByYear W20443322162021 @default.
- W2044332216 countsByYear W20443322162022 @default.
- W2044332216 countsByYear W20443322162023 @default.
- W2044332216 crossrefType "journal-article" @default.
- W2044332216 hasAuthorship W2044332216A5000245553 @default.
- W2044332216 hasAuthorship W2044332216A5000363531 @default.
- W2044332216 hasAuthorship W2044332216A5002855077 @default.
- W2044332216 hasAuthorship W2044332216A5012763993 @default.
- W2044332216 hasAuthorship W2044332216A5025104162 @default.
- W2044332216 hasAuthorship W2044332216A5028620086 @default.
- W2044332216 hasAuthorship W2044332216A5048762031 @default.
- W2044332216 hasAuthorship W2044332216A5053670205 @default.
- W2044332216 hasAuthorship W2044332216A5066792775 @default.
- W2044332216 hasAuthorship W2044332216A5072475973 @default.
- W2044332216 hasAuthorship W2044332216A5082857859 @default.
- W2044332216 hasAuthorship W2044332216A5088958812 @default.
- W2044332216 hasConcept C109316439 @default.
- W2044332216 hasConcept C12554922 @default.
- W2044332216 hasConcept C150903083 @default.
- W2044332216 hasConcept C171250308 @default.